1. Home
  2. QBTS vs CYTK Comparison

QBTS vs CYTK Comparison

Compare QBTS & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D-Wave Quantum Inc.

QBTS

D-Wave Quantum Inc.

HOLD

Current Price

$19.15

Market Cap

7.8B

Sector

Technology

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$67.52

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QBTS
CYTK
Founded
1999
1997
Country
US
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.0B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
QBTS
CYTK
Price
$19.15
$67.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
17
Target Price
$32.80
$85.24
AVG Volume (30 Days)
26.7M
1.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.49
EPS
N/A
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
$196.28
$341.94
Revenue Next Year
$54.79
$50.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.45
$29.31
52 Week High
$46.75
$70.98

Technical Indicators

Market Signals
Indicator
QBTS
CYTK
Relative Strength Index (RSI) 40.04 58.52
Support Level $17.81 $64.58
Resistance Level $19.62 $67.67
Average True Range (ATR) 1.78 2.73
MACD -0.05 0.37
Stochastic Oscillator 35.48 94.32

Price Performance

Historical Comparison
QBTS
CYTK

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: